Personalized Cancer Vaccine

We first collect tumor tissue from a cancer patient and use sequencing technology to identify unique cancer neoantigens. Then, we modify the sequence of these neoantigens and leverage our independently developed vector platform to design personalized cancer vaccines for each individual patient. Finally, we optimize the dosage and administer the regimen to the patient to achieve optimal therapeutic outcomes.